Biological Properties of Curcumin-Cellular and Molecular Mechanisms of Action
暂无分享,去创建一个
[1] L. O’Neill,et al. Inhibition of nuclear factor kappaB by direct modification in whole cells--mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. , 1998, Biochemical pharmacology.
[2] Jen-kun Lin,et al. Biotransformation of curcumin through reduction and glucuronidation in mice. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[3] D. Shoskes,et al. The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischemia reperfusion injury and repair. , 2000, The Journal of urology.
[4] Y. Awasthi,et al. Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. , 1998, The international journal of biochemistry & cell biology.
[5] B. Aggarwal,et al. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. , 1995, The Journal of biological chemistry.
[6] B. H. Shah,et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. , 1999, Biochemical pharmacology.
[7] Ashutosh Kumar Singh,et al. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[8] V. Lad. An introduction to Ayurveda. , 1995, Alternative therapies in health and medicine.
[9] N. Shirasaka,et al. Inhibition of rat liver microsomal desaturases by curcumin and related compounds. , 1996, Bioscience, biotechnology, and biochemistry.
[10] Seon-Hwa Lee,et al. Vitamin C-Induced Decomposition of Lipid Hydroperoxides to Endogenous Genotoxins , 2001, Science.
[11] D. Karunagaran,et al. L-929 Cells Harboring Ectopically Expressed RelA Resist Curcumin-induced Apoptosis* , 2000, The Journal of Biological Chemistry.
[12] H. Kleinman,et al. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[13] K. Ferrell,et al. Comparison of human COP9 signalosome and 26S proteasome ‘lid’ , 1999, Molecular Biology Reports.
[14] O A Iakimenko,et al. [Anti-inflammatory agents]. , 1984, Fel'dsher i akusherka.
[15] T. Masuda,et al. Protective actions of 5'-n-alkylated curcumins on living cells suffering from oxidative stress. , 1998, European journal of pharmacology.
[16] J. Williams,et al. Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa B. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[17] B. Aggarwal,et al. Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.
[18] Ashutosh Kumar Singh,et al. Enhancement of wound healing by curcumin in animals , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[19] G. Pavlath,et al. Systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury. , 1999, American journal of physiology. Cell physiology.
[20] S. Han,et al. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. , 1999, Clinical immunology.
[21] A. Mukherjee,et al. Studies on the anticlastogenic effect of turmeric and curcumin on cyclophosphamide and mitomycin C in vivo. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[22] M. Hung,et al. Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] H. Ohshima,et al. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. , 1995, Biochemical and biophysical research communications.
[24] K. N. Rajasekharan,et al. Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. , 1996, Mutation research.
[25] M. Klagsbrun,et al. AP-1 mediates stretch-induced expression of HB-EGF in bladder smooth muscle cells. , 1999, American journal of physiology. Cell physiology.
[26] R. Srimal,et al. Pharmacology of diferuloyl methane (curcumin), a non‐steroidal anti‐inflammatory agent * , 1973, The Journal of pharmacy and pharmacology.
[27] M. Rao,et al. Nitric Oxide Scavenging by Curcuminoids , 1997, The Journal of pharmacy and pharmacology.
[28] K. Frenkel,et al. Inhibitory effects of curcumin on tumorigenesis in mice , 1997, Journal of cellular biochemistry. Supplement.
[29] V. Steele,et al. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. , 2000, The Journal of nutrition.
[30] P. Verger,et al. Estimation of the distribution of the maximum theoretical intake for ten additives in France. , 1998, Food additives and contaminants.
[31] B. Lokesh,et al. Effect of curcumin and eugenol on iron-induced hepatic toxicity in rats. , 1996, Toxicology.
[32] D. Zhou,et al. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. , 1999, Anticancer research.
[33] C. Boone,et al. Biomarker end-points in cancer chemoprevention trials. , 1997, IARC scientific publications.
[34] T. Miyata,et al. Methylglyoxal induces apoptosis in Jurkat leukemia T cells by activating c‐Jun N‐Terminal kinase , 2000, Journal of cellular biochemistry.
[35] M. Bertagnolli,et al. Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. , 2000, The Journal of surgical research.
[36] Y. P. Lu,et al. Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. , 1995, Carcinogenesis.
[37] B. Aggarwal,et al. Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. , 1998, Biochemical pharmacology.
[38] M. K. Heng,et al. Drug‐induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters , 2000, The British journal of dermatology.
[39] E. Bahraoui,et al. Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. , 1998, Research in virology.
[40] K. Kohn,et al. Hydroxylated aromatic inhibitors of HIV-1 integrase. , 1995, Journal of medicinal chemistry.
[41] B. Joe,et al. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. , 1994, Biochimica et biophysica acta.
[42] K. Srinivasan,et al. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats , 2004, Molecular and Cellular Biochemistry.
[43] H. Ammon,et al. Pharmacology of Curcuma longa , 1991, Planta medica.
[44] B. Joe,et al. Dietary n-3 fatty acids, curcumin and capsaicin lower the release of lysosomal enzymes and eicosanoids in rat peritoneal macrophages , 2004, Molecular and Cellular Biochemistry.
[45] N. Sreejayan,et al. Free radical scavenging activity of curcuminoids. , 1996, Arzneimittel-Forschung.
[46] Jen-kun Lin,et al. Stability of curcumin in buffer solutions and characterization of its degradation products. , 1997, Journal of pharmaceutical and biomedical analysis.
[47] C. Rao,et al. Chemoprevention of Colon Cancer by Dietary Curcumin , 1995, Annals of the New York Academy of Sciences.
[48] R. Puvanakrishnan,et al. Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats. , 1996, Biochemical pharmacology.
[49] R. Puvanakrishnan,et al. Effect of curcumin on cetrain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats , 1996 .
[50] Huei-Wen Chen,et al. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells , 1998, British journal of pharmacology.
[51] T. Luther,et al. The Dietary Pigment Curcumin Reduces Endothelial Tissue Factor Gene Expression by Inhibiting Binding of AP-1 to the DNA and Activation of NF-κB , 1997, Thrombosis and Haemostasis.
[52] H. Ciolino,et al. Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. , 1998, Biochemical pharmacology.
[53] Jen-kun Lin,et al. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin , 1997, Journal of cellular biochemistry. Supplement.
[54] B. Rigas,et al. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. , 1997, The Journal of laboratory and clinical medicine.
[55] R. Foresti,et al. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. , 2000, Free radical biology & medicine.
[56] L. Stanberry,et al. Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2. , 1999, Antiviral research.
[57] R. Lodha,et al. Traditional Indian systems of medicine. , 2000, Annals of the Academy of Medicine, Singapore.
[58] L. Howells,et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. , 2001, Cancer research.
[59] M. Osborne,et al. Phytochemicals as modulators of cancer risk. , 1999, Advances in experimental medicine and biology.
[60] B. Joe,et al. Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages , 1997, Lipids.
[61] N. Chandrasekhara,et al. Effect on curcumin on cholesterol gall-stone induction in mice. , 1992, The Indian journal of medical research.
[62] C. Hertel,et al. Beta-amyloid binds to p57NTR and activates NFkappaB in human neuroblastoma cells. , 1998, Journal of neuroscience research.
[63] M. Sugano,et al. Effect of natural food colorings on immunoglobulin production in vitro by rat spleen lymphocytes. , 1996, Bioscience, biotechnology, and biochemistry.
[64] K. Srinivasan,et al. Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat , 1995, Molecular and Cellular Biochemistry.
[65] Y. Lou,et al. Some Perspectives on Dietary Inhibition of Carcinogenesis: Studies with Curcumin and Tea , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[66] D. Brenner,et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.
[67] M. Jiang,et al. Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine. , 1996, Biochemical and biophysical research communications.
[68] T C Chou,et al. Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. , 1998, Carcinogenesis.
[69] G. Kuttan,et al. Immunomodulatory activity of curcumin. , 1999, Immunological investigations.
[70] R. Puvanakrishnan,et al. Curcumin treatment modulates collagen metabolism in isoprot3erenol induced myoxardial necrosis in rats , 1999, Molecular and Cellular Biochemistry.
[71] N. Venkatesan,et al. Curcumin prevents adriamycin nephrotoxicity in rats , 2000, British journal of pharmacology.
[72] A. Tantaoui-Elaraki,et al. Growth and toxigenesis of Aspergillus flavus isolates on selected spices. , 1997, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[73] A G Renwick,et al. An analysis of the possibility for health implications of joint actions and interactions between food additives. , 2000, Regulatory toxicology and pharmacology : RTP.
[74] B. Lokesh,et al. Effect of dietary turmeric (Curcuma longa) on iron-induced lipid peroxidation in the rat liver. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[75] M. Dikshit,et al. Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart. , 1995, The Indian journal of medical research.
[76] M. Giacca,et al. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1 , 1996, Journal of virology.
[77] J. Lin,et al. Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[78] R. Gaynor,et al. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. , 1998, Nature.
[79] S. Hwang,et al. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin‐12 production in macrophages , 1999, British journal of pharmacology.
[80] Y. Surh,et al. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. , 1999, Mutation research.
[81] T. Tan,et al. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin , 1998, Oncogene.
[82] A. Conney,et al. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells. , 1997, Oncology research.
[83] K. Kato,et al. Stimulation of the stress-induced expression of stress proteins by curcumin in cultured cells and in rat tissues in vivo. , 1998, Cell stress & chaperones.
[84] C. Rao,et al. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. , 1995, Cancer research.
[85] L. Chaudhary,et al. Regulation of Interleukin-8 Gene Expression by Interleukin-1β, Osteotropic Hormones, and Protein Kinase Inhibitors in Normal Human Bone Marrow Stromal Cells* , 1996, The Journal of Biological Chemistry.
[86] A. Dinkova-Kostova,et al. Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. , 1999, Carcinogenesis.
[87] C. Crumpacker,et al. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[88] B. Aggarwal,et al. The p60 Tumor Necrosis Factor (TNF) Receptor-associated Kinase (TRAK) Binds Residues 344–397 within the Cytoplasmic Domain Involved in TNF Signaling (*) , 1995, The Journal of Biological Chemistry.
[89] T. Osawa,et al. Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. , 1999, Carcinogenesis.
[90] B. Pardhasaradhi,et al. Curcumin mediated apoptosis in AK‐5 tumor cells involves the production of reactive oxygen intermediates , 1999, FEBS letters.
[91] L. Antunes,et al. Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells. , 2000, Mutation research.
[92] K. Platel,et al. Influence of dietary spices and their active principles on pancreatic digestive enzymes in albino rats. , 2000, Die Nahrung.
[93] K. C. Srivastava,et al. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. , 1995, Prostaglandins, leukotrienes, and essential fatty acids.
[94] Jen-kun Lin,et al. Curcumin Inhibits SK-Hep-1 Hepatocellular Carcinoma Cell Invasion in vitro and Suppresses Matrix Metalloproteinase-9 Secretion , 1998, Oncology.
[95] H. Cohly,et al. Effect of turmeric, turmerin and curcumin on H2O2-induced renal epithelial (LLC-PK1) cell injury. , 1998, Free radical biology & medicine.
[96] L. Howells,et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.
[97] C. Takahashi,et al. Modulatory effects of curcumin on the chromosomal damage induced by doxorubicin in Chinese hamster ovary cells. , 1999, Teratogenesis, carcinogenesis, and mutagenesis.
[98] R. Kumar,et al. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. , 1995, Carcinogenesis.
[99] M. Chan,et al. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. , 1998, Biochemical pharmacology.
[100] Jen-kun Lin,et al. Induction of HSP70 gene expression by modulation of Ca+2 ion and cellular p53 protein by curcumin in colorectal carcinoma cells , 1996, Molecular carcinogenesis.
[101] J. Pezzuto,et al. Evaluation of the potential of cancer chemopreventive activity mediated by inhibition of 12-O-tetradecanoyl phorbol 13-acetate-induced ornithine decarboxylase activity , 1999, Archives of pharmacal research.
[102] B. Joe,et al. Prophylactic and therapeutic effects of n-3 polyunsaturated fatty acids, capsaicin, and curcumin on adjuvant induced arthritis in rats , 1997 .
[103] G. Wu,et al. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. , 1998, The American surgeon.
[104] S. Gautam,et al. Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane). , 1998, Biochemical pharmacology.
[105] C. Franceschi,et al. Apoptosis‐like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes , 1998, FEBS letters.
[106] G. Kuttan,et al. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. , 1995, Cancer letters.
[107] Jen-kun Lin,et al. Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. , 1996, Nutrition and cancer.
[108] C. Hertel,et al. β‐amyloid binds to p75NTR and activates NFκB in human neuroblastoma cells , 1998 .
[109] T. Masuda,et al. Chemical studies on antioxidant mechanism of curcumin: analysis of oxidative coupling products from curcumin and linoleate. , 2001, Journal of agricultural and food chemistry.
[110] H. Ahsan,et al. Strand scission in DNA induced by curcumin in the presence of Cu(II). , 1998, Cancer letters.
[111] Y. P. Lu,et al. Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. , 1998, Carcinogenesis.
[112] Y. Awasthi,et al. Curcumin protects against 4-hydroxy-2-trans-nonenal-induced cataract formation in rat lenses. , 1996, The American journal of clinical nutrition.
[113] H. Ahsan,et al. Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. , 1999, Chemico-biological interactions.
[114] L. Leon,et al. Biological activities of Curcuma longa L. , 2001, Memorias do Instituto Oswaldo Cruz.
[115] F. Bonte,et al. Protective effect of curcuminoids on epidermal skin cells under free oxygen radical stress. , 1997, Planta medica.
[116] S. Onodera,et al. Macrophage Migration Inhibitory Factor Up-regulates Expression of Matrix Metalloproteinases in Synovial Fibroblasts of Rheumatoid Arthritis* , 2000, The Journal of Biological Chemistry.
[117] E. Sudharshan,et al. Inhibition of lipoxygenase 1 by phosphatidylcholine micelles-bound curcumin , 1998, Lipids.
[118] T. P. Krishnakantha,et al. Influence of retinol deficiency and curcumin/turmeric feeding on tissue microsomal membrane lipid peroxidation and fatty acids in rats , 1997, Molecular and Cellular Biochemistry.
[119] A. Sokal,et al. Apoptosis-independent alterations in membrane dynamics induced by curcumin. , 1998, Experimental cell research.
[120] R. C. Srimal,et al. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis. , 1986, Arzneimittel-Forschung.
[121] Y. Pommier,et al. Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. , 1997, Journal of medicinal chemistry.
[122] K. Mohandas,et al. Epidemiology of digestive tract cancers in India. V. Large and small bowel. , 1999, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[123] M. Chan. Inhibition of tumor necrosis factor by curcumin, a phytochemical. , 1995, Biochemical pharmacology.
[124] J. Santibañez,et al. Genistein and Curcumin Block TGF-β1-Induced u-PA Expression and Migratory and Invasive Phenotype in Mouse Epidermal Keratinocytes , 2000, Nutrition and cancer.
[125] C. Takahashi,et al. Potentiation by turmeric and curcumin of gamma-radiation-induced chromosome aberrations in Chinese hamster ovary cells. , 1999, Teratogenesis, carcinogenesis, and mutagenesis.
[126] N. Ohta,et al. Trypanocidal effects of curcumin in vitro. , 1998, Biological & pharmaceutical bulletin.
[127] Rasyid,et al. The effect of curcumin and placebo on human gall‐bladder function: an ultrasound study , 1999, Alimentary pharmacology & therapeutics.
[128] B. Ghosh,et al. Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. , 1999, International journal of immunopharmacology.
[129] E. Skrzypczak‐Jankun,et al. Curcumin inhibits lipoxygenase by binding to its central cavity: theoretical and X-ray evidence. , 2000, International journal of molecular medicine.
[130] R. Gaynor,et al. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.
[131] M. Kottke. Scientific and regulatory aspects of nutraceutical products in the United States. , 1998, Drug development and industrial pharmacy.
[132] Jen-kun Lin,et al. Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. , 2000, Carcinogenesis.
[133] A. Wilson,et al. Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[134] Jen-kun Lin,et al. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. , 1996, Biochimica et biophysica acta.
[135] E. Sudharshan,et al. Interaction of curcumin with human serum albumin—A spectroscopic study , 1999, Lipids.
[136] D. Scholz,et al. Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. , 1999, Journal of ethnopharmacology.
[137] G. Kuttan,et al. Anti-metastatic activity of curcumin and catechin. , 1999, Cancer letters.
[138] J. Exon,et al. Dietary curcumin enhances antibody response in rats. , 1997, Immunopharmacology and immunotoxicology.
[139] R. K. Bhattacharya,et al. Action of curcumin on the cytochrome P450-system catalyzing the activation of aflatoxin B1. , 1996, Chemico-biological interactions.
[140] S. Jee,et al. Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. , 1998, The Journal of investigative dermatology.
[141] R. Buttyan,et al. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo , 2001, The Prostate.
[142] E. Novellino,et al. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling. , 1998, Journal of medicinal chemistry.
[143] H. Yamamoto,et al. Inhibitory effect of curcumin on mammalian phospholipase D activity , 1997, FEBS letters.
[144] N. Vermeulen,et al. Cytotoxicity and cytoprotective activities of natural compounds. The case of curcumin. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.
[145] Y. Oda,et al. Inhibitory effect of curcumin on SOS functions induced by UV irradiation. , 1995, Mutation research.
[146] K. Piwocka,et al. Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. , 1997, Biochemical pharmacology.
[147] B. Joe,et al. Presence of an acidic glycoprotein in the serum of arthritic rats: Modulation by capsaicin and curcumin , 1997, Molecular and Cellular Biochemistry.
[148] B. Premalatha,et al. Dietary curcumin with cisplatin administration modulates tumour marker indices in experimental fibrosarcoma. , 1999, Pharmacological Research.
[149] U. Pastorino,et al. Suppression of tumour development by substances derived from the diet--mechanisms and clinical implications. , 1998, British journal of clinical pharmacology.
[150] G. Maru,et al. Effects of curcumin on the formation of benzo[a]pyrene derived DNA adducts in vitro. , 1995, Cancer letters.
[151] M. Majeed,et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.
[152] V. Steele,et al. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. , 1999, Cancer research.